European consensus table on the use of botulinum toxin type A in adult spasticity.

Authors

  • Jörg Wissel
  • Anthony B. Ward
  • Per Ertzgaard
  • Djamel Bensmail
  • Martin J. Hecht
  • Thierry Lejeune
  • Peter Schnider

DOI:

https://doi.org/10.2340/16501977-0303

Keywords:

botulinum toxin, upper motor neurone syndrome, adult spasticity, acquired brain injury.

Abstract

A group of clinicians from across Europe experienced in the use of botulinum toxin type A for the treatment of spasticity following acquired brain injury gathered to develop a consensus statement on best practice in managing adults with spasticity. This consensus table summarizes the current published data, which was collated following extensive literature searches, their assessment for level of evidence and discussion among the whole group. Published information is supplemented by expert opinion based on clinical experience from 16 European countries, involving 28 clinicians, who treat an average of approximately 200 patients annually, representing many thousand spasticity treatments with botulinum toxin per year.

Downloads

Download data is not yet available.

Downloads

Published

2008-12-05

How to Cite

Wissel, J., Ward, A. B., Ertzgaard, P., Bensmail, D., Hecht, M. J., Lejeune, T., & Schnider, P. (2008). European consensus table on the use of botulinum toxin type A in adult spasticity. Journal of Rehabilitation Medicine, 41(1), 13–25. https://doi.org/10.2340/16501977-0303

Issue

Section

Special Report